Ciphergen Biosystems
About:
Ciphergen Biosystems is focused on the discovery, development and commercialization of high-value, molecular diagnostic products.
Top Investors: Bio-Rad Laboratories, Morgan Stanley Expansion Capital, Amadeus Capital Partners
Description:
Ciphergen Biosystems, Inc. is focused on the discovery, development and commercialization of high-value, molecular diagnostic products to improve patient care. Ciphergen, along with its prestigious scientific collaborators, has ongoing diagnostic programs primarily in oncology with an initial focus in ovarian and prostate cancer. Based in Fremont, California
Total Funding Amount:
$32M
Headquarters Location:
Fremont, California, United States
Founded Date:
Founders:
Number of Employees:
Last Funding Date:
2006-08-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai